Trinity Biotech annual gross margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Trinity Biotech Gross Margin Growth & History (TRIB)
Trinity Biotech's gross margin was 34.83% for fiscal 2024.
View full Trinity Biotech company overviewTrinity Biotech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 34.83% | +0.61 pp |
| 2023 | 2023-12-31 | 34.22% | +6.60 pp |
| 2022 | 2022-12-31 | 27.62% | −13.61 pp |
| 2021 | 2021-12-31 | 41.23% | −6.41 pp |
| 2020 | 2020-12-31 | 47.64% | +5.48 pp |
| 2019 | 2019-12-31 | 42.15% | −0.56 pp |
| 2018 | 2018-12-31 | 42.72% | +0.46 pp |
| 2017 | 2017-12-31 | 42.25% | −1.40 pp |
| 2016 | 2016-12-31 | 43.65% | −2.77 pp |
| 2015 | 2015-12-31 | 46.42% | — |
Trinity Biotech quarterly gross margin
Q2.17
Q2.18
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2018 | 2018-06-30 | 43.23% | — |
| Q2 2017 | 2017-06-30 | 42.51% | — |
Trinity Biotech gross margin trends
Over the last five reported fiscal years, Trinity Biotech's gross margin decreased from 42.15% to 34.83%, a change of −7.32 percentage points. The latest reported quarter, Q2 2018, shows 43.23%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech filings at SEC.gov ↗